Home
Clinical Trials
Arthroplasty Cements Outcomes...

Arthroplasty Cements Outcomes - A Post-market Follow-up

Last Updated: 2025-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1050 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-16

Study Completion Date

2045-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Post-Market Clinical Follow-Up (PMCF) Study to collect clinical data on safety and performance of all Teknimed Arthroplasty range of products: CEMFIX® and GENTAFIX® bone cements families and CEMSTOP® cement restrictor, and all their private labels.

Teknimed bone cements and cement restrictor are legacy products, some marketed for more than 20 years. Their performance and safety have already been demonstrated by Post-Market Surveillance and previous clinical studies. The current Post-Market Clinical Follow-Up study aims to confirm these claims by collecting data in a "real-life" setting.

The study is a retrospective and prospective global, single arm, non-controlled, multicentric, ambispective observational study. Patients will be followed as per local standard medical care of the site.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

NexGen TM Tibia Clinical Outcomes Study

NCT03272373

Osteoarthritis Rheumatoid Arthritis Traumatic Arthritis +4 more

COMPLETED NA

A Migration and Bone Density Study Comparing 2 Types of Bone Cement in the OptiPac Bone Cement Mixing System

NCT00678236

Osteoarthritis

COMPLETED NA

Total Knee Arthroplasty (TKA) Cemented Versus Cementless Tibial Prosthesis Study

NCT01041937

Osteoarthritis Post-traumatic Osteoarthritis Rheumatoid Arthritis

COMPLETED NA

A Prospective, Post-marketing Registry on the Use of ChondroMimetic for the Repair of Osteochondral Defects

NCT01209390

Osteochondral Defects

TERMINATED

Autograft Versus Calcium Phosphate Macroporous Bioceramics as Bone Substitute for Tibial Valgus Osteotomy

NCT00200603

Osteoarthritis of the Knee

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is admitted that:

* Joint replacement is a commonly performed major surgical procedure that has considerable success in alleviating pain and disability;
* These procedures may be done with the help of a bone cement (PMMA) to fix the prosthesis to the bone (cemented fixation);
* Most common reasons for primary joint replacement are osteoarthritis, osteonecrosis and trauma;
* Most common reasons for revision of joint replacement are dislocation, infection, fracture and prothesis loosening;
* Quality of bone cement have a large influence on long-term implant stability.

TEKNIMED has developed several bone cements and a cement restrictor currently used in arthroplasty procedures.

With the increasing use of these procedures, there is a need of real-life long-term safety and efficacy data on the bone cements.

This retro- and prospective study is performed to assess the safety and performance of TEKNIMED arthroplasty products in their current clinical use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthroplasty

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.